QUOTED. Suzanne Schwartz.
The US FDA issued a new guidance on 8 April that outlines a comprehensive approach device manufacturers can take to address cybersecurity concerns throughout the total product life cycle of their products. See what Suzanne Schwartz, director of the agency’s Office of Strategic Partnerships and Technology Innovation, said about it here.
“Right now it's really key to have manufacturers understand the aspect of free markets that extends well beyond the device becoming authorized to go on the market.” – Suzanne Schwartz, director, US FDA Office of Strategic Partnerships and Technology Innovation
Click here for a free trial of Medtech Insight